Cited by 80Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of LifePalliative Care and End-of-Life Issues

Risks and benefits of screening for dementia in primary care: the Indiana University cognitive health outcomes investigation of the comparative effectiveness of dementia screening (IU CHOICE) trial

Open access
Fowler, Nicole R., Perkins, Anthony J., Gao, Sujuan, Sachs, Greg A., Boustani, Malaz A.·2020·Journal of the American Geriatrics Society

Abstract

BACKGROUND/OBJECTIVE: The benefits and harms of screening of Alzheimer disease and related dementias (ADRDs) are unknown. This study addressed the question of whether the benefits outweigh the harms of screening for ADRDs among older adults in primary care. DESIGN, SETTING, AND PARTICIPANTS: Single‐blinded, two‐arm, randomized controlled trial (October 2012‐September 2016) in urban, suburban, and rural primary care settings in Indiana. A total of 4005 primary care patients (aged ≥65 years) were randomized to ADRD screening (n = 2008) or control (n = 1997). INTERVENTION: Patients were screened using the Memory Impairment Screen or the Mini‐Cog and referred for a voluntary follow‐up diagnostic assessment if they screened positive on either or both screening tests. MEASUREMENTS: Primary measures were health‐related quality of life (HRQOL; Health Utilities Index) at 12 months, depressive symptoms (Patient Health Questionnaire‐9), and anxiety symptoms (Generalized Anxiety Disorder seven‐item scale) at 1 month. RESULTS: The mean age was 74.2 years (SD = 6.9 years); 2257 (66%) were female and 2301 (67%) were white. At 12 months, we were unable to detect differences in HRQOL between the groups (effect size = 0.009 [95% confidence interval {CI} = −0.063 to 0.080]; P = .81). At 1 month, differences in mean depressive symptoms (mean difference = −0.23 [90% CI = −0.42 to ‐0.039]) and anxiety symptoms (mean difference = −0.087 [90% CI = −0.246 to 0.072]) were within prespecified equivalency range. Scores for depressive and anxiety symptoms were similar between the groups at all time points. No differences in healthcare utilization, advance care planning, and ADRD recognition by physicians were detected at 12 months. CONCLUSION: We were unable to detect a difference in HRQOL for screening for ADRD among older adults. We found no harm from screening measured by symptoms of depression or anxiety. Missing data, low rates of dementia detection, and high rate of refusal for follow‐up diagnostic assessments after a positive screen may explain these findings. J Am Geriatr Soc 68:535–543, 2020

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jgs.16247

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Although CSF Aβ1-42/1-40 ratio and amyloid PET are considered interchangeable, CSF tau biomarkers have only correlated weakly with brain tau as measured by radioligands.

    “Although CSF Aβ1–42/1–40 ratio and amyloid PET are now considered interchangeable,191 CSF tau biomarkers have only correlated weakly with brain tau as currently measured by radioligands.192”

    From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [192]

    Citation 192 is attached to the claim about CSF tau biomarkers and radioligand-measured brain tau. The Methods and Discussion of the IU CHOICE trial address primary-care cognitive screening, not that biomarker correlation; searches for CSF tau, tau PET, and radioligands found no relevant passage in our copy. No page numbers were provided for the indexed passages. (LLM, conf=0.77)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [41]Boustani MA, Jemoumi R, Munger S: Forecasting the future impact of early detection and management Program for Alzheimer disease. Am J Geriatr Psychiatr. 2009, 17: A9– A149.
  2. [44]Callahan CM, Hendrie HC, Tierney WM: Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Int Med. 1995, 122 (6): 422– 429. 7856990

Cited by

Sorted by citations

Authors
Fowler, N. R., Perkins, A. J., Gao, S., Sachs, G. A., & Boustani, M. A.
Affiliations
  • Regenstrief Institute (US)
  • Indiana University Indianapolis (US)
Corresponding author
Fowler, Nicole R.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2019-12-02
Volume
68
Issue
3
Pages
535-543
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W2991026540
Cited by
79
References
54
Citations by year
2026: 9 · 2025: 14 · 2024: 11 · 2023: 14 · 2022: 11 · 2021: 8 · 2020: 12
FWCI
6.17
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Geriatrics Society (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
  • Purdue University Indianapolis (Indiana University) (submittedVersion)
Funders
National Institute on Aging (R01AG040220)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
Keywords
dementia screening, Alzheimer's disease and related dementias, primary care, older adults, health-related quality of life, depressive symptoms, anxiety symptoms, Mini-Cog, screening harms, advance care planning, health care utilization, comparative effectiveness
MeSH terms
Aged, Dementia, Female, Humans, Indiana, Male, Mass Screening, Neuropsychological Tests, Primary Health Care, Quality of Life, Universities, Outcome Assessment, Health Care, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review